PTTG1 and neoplasm: Notably, compared with PTTG1 and S100A8, approximately 50% MRS1-tumor cells expressed S100A7, with a 34-fold change than the expression percentage in MRS2-tumor cells (Figure S9C, D, Supplementary Table 4).